White House Government Agencies

More

  • *Chinese imports from Hong Kong surge in September. LONDON, Oct 27- Gold steadied above $1,160 an ounce as caution ahead of a Federal Reserve meeting starting on Tuesday pegged prices within a narrow range, with buyers awaiting clues on the timing of a possible U.S. interest rate hike. Spot gold was at $1,162.45 an ounce at 1313 GMT, little changed from $1,162.80 late...

  • LONDON, Oct 27- Emerging market equities were on course for their fifth decline in six days on Tuesday and currencies weakened before two key central bank meetings, as a rally built on further stimulus hopes fizzled out. MSCI's benchmark emerging equity index fell 0.6 percent on Tuesday as Russian stocks dropped 2.4 percent and shares fell on some Asian and...

  • *Chinese imports from Hong Kong surge in September. LONDON, Oct 27- Gold firmed on Tuesday, as caution ahead of a Federal Reserve meeting starting later in the day weighed on risk appetite and the dollar eased, but moves were muted as buyers awaited clues on the timing of a possible U.S. interest rate hike. Spot gold was up 0.3 percent at $1,165.91 an ounce at 1032 GMT,...

  • *UK GDP data eyed for BoE rate expectations. LONDON, Oct 27- The safe-haven yen gained on Tuesday, hitting a seven-week high against the euro, as investors turned risk-averse before the start of a two-day meeting of the U.S. The yen had fallen last week, hitting a two-month low against the dollar after the European Central Bank said it was ready to loosen policy...

  • ZURICH, Oct 27- Novartis has agreed in principle to pay $390 million to settle U.S. allegations that it used kickbacks to speciality pharmacies to push sales of some drugs, the Swiss company said on Tuesday, hitting third-quarter earnings. The U.S. Department of Justice had sued Novartis in the Manhattan federal court, saying the world's biggest seller of...

  • *China shares lead markets lower across region. HONG KONG, Oct 27- Asian shares fell on Tuesday after a four-week rally ran out of steam as investors took cover ahead of central bank meetings in the United States and Japan later in the week, while disappointing U.S. home sales weighed on the dollar. MSCI's broadest index of Asia-Pacific shares outside Japan slipped...

  • SINGAPORE, Oct 27- Gold steadied near $1,160 an ounce on Tuesday as investors kept to the sidelines ahead of a Federal Reserve policy meeting that kicks off later in the session, waiting for clues on the timing of a U.S. rate hike. *Spot gold was steady at $1,162.96 an ounce by 0027 GMT. The metal had fallen to its lowest in nearly two weeks at $1,158.77 on Friday, but has...

  • NEW YORK, Oct 26- Global equity markets slipped on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the United States and Japan later in the week, while the dollar weakened in the wake of soft U.S. housing data. Stock markets rallied last week on the potential that Japan's already-massive stimulus would be further...

  • Oct 26- A U.S. judge on Monday expressed strong doubts that he had the legal authority to order Apple Inc to access data on a locked iPhone that was seized as part of a federal investigation. Magistrate Judge James Orenstein told government attorneys at a hearing in Brooklyn federal court. Orenstein asked Apple and the U.S. Justice Department for arguments on the...

  • Oct 26- U.S. federal prosecutors are preparing to announce criminal charges against a former Goldman Sachs banker alleged to have obtained confidential documents from the Federal Reserve Bank of New York, a person familiar with matter said on Monday. Separately, the New York Department of Financial Services is looking at fining Goldman Sachs $50 million and...

  • NEW YORK, Oct 26- Global equity markets edged lower on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the U.S. and Japan later in the week, while the dollar lost ground in the wake of soft U.S. housing data. Stock markets rallied last week on bets that Japan's already-massive stimulus would be further increased after...

  • Oct 26- U.S. health regulators said on Monday that there was no evidence of increased cardiovascular risks related to Novartis AG's treatment, Stalevo, for Parkinson's disease. Recommendations for using the drug, which won U.S. approval in 2003, will remain the same on the labels, the U.S. Food and Drug Administration said, after examining data from a required...

  • Oct 26- U.S. federal prosecutors are planning to announce a criminal case this week against a former Goldman Sachs Group Inc banker suspected of taking confidential documents from a government employee, the New York Times reported. When Bansal joined Goldman in July 2014, he was assigned to advise one of the same banks he had previously regulated when he worked...

  • NEW YORK, Oct 26- The dollar fell from a 2-1/ 2- month high versus a basket of major currencies on Monday on lower U.S. bond yields and a drop in U.S. new home sales in September that revived concerns about the U.S. economy before a two-day Federal Reserve policy meeting. The dollar index just booked its best week since mid-May as investor sentiment improved following...

  • NEW YORK, Oct 26- Global equity markets slipped on Monday, pausing after a four-week rally ahead of policy announcements from central banks in the U.S. and Japan later in the week, while the dollar lost ground in the wake of soft U.S. housing data. Investors had recently raised bets that Japan's already-massive stimulus would be further increased after China cut...

  • Oct 26- U.S. stocks were little changed on Monday ahead of this week's Federal Reserve policy meeting and quarterly earnings reports from key companies including Apple.

  • *Gold still not far from near two-week lows. LONDON, Oct 26- Gold inched up on Monday after a three-day losing streak, as the dollar's ascent paused and uncertainty persisted over the timing of the first Federal Reserve rate increase in a decade. Gold had risen 1 percent soon after China's surprise interest rate cut on Friday, as investors bet the U.S. central bank...

  • Oct 26- BioDelivery Sciences International Inc said the U.S. Food and Drug Administration had approved its opioid treatment for chronic pain, sending the drugmaker's shares up 19 percent in premarket trading on Monday. Endo International Plc licensed the worldwide manufacturing and marketing rights to the treatment, Belbuca, from BioDelivery in 2012..

  • BioDelivery's opioid treatment wins FDA approval Monday, 26 Oct 2015 | 6:15 AM ET

    Oct 26- The U.S. Food and Drug Administration has approved BioDelivery Sciences International Inc's opioid treatment for chronic pain, the company said on Monday. Endo International Plc licensed the worldwide manufacturing and marketing rights to the treatment, Belbuca, from BioDelivery in 2012.. Belbuca is an opioid film patch and aims to treat patients...

  • SAN FRANCISCO, Oct 26- Federal Reserve Chair Janet Yellen, praised as an adept listener and consensus builder, may need to adopt a stronger tone at this week's policy meeting if she expects to keep a December interest rate rise in play. Yellen's inclusive style has been tested recently by two fellow governors who publicly appeared to disagree with her view, shared...